Rhaeos company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Founded Year



Seed VC | Alive

Total Raised


Last Raised

$2.2M | 5 mos ago

About Rhaeos

Rhaeos was founded in 2018 to address a critical unmet need in the care of patients with hydrocephalus. Arising from a collaboration between materials scientists and neurological surgeons at Northwestern University, the company has developed a noninvasive thermal sensor for use in the monitoring of ventricular shunt function.

Rhaeos Headquarter Location

2123 Dewey Ave

Evanston, Illinois, 60201,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Rhaeos

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Rhaeos is included in 4 Expert Collections, including Medical Devices.


Medical Devices

8,279 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Digital Health

12,800 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health Monitoring & Diagnostics

462 items

Companies developing wearable health monitoring solutions (human health only). Companies tagged as #Wearables (*note: this tag may also apply to companies outside the scope of this collection)


Health IT

7,900 items

Latest Rhaeos News

Rhaeos Gets Patents Covering Wearable Non-Invasive Fluid Flow Monitoring Sensors

Apr 9, 2022

Private medical device company Rhaeos , which is focused on the care of patients with chronic medical conditions, announced the issuance of U.S. patents  that cover flexible, wearable sensors for non-invasive monitoring of subdermal fluid flow. These patents include wearable sensors that address cerebrospinal fluid in hydrocephalus shunts and blood flow in both capillaries and large vessels. Biological fluid flow is a key diagnostic and therapeutic biomarker for numerous chronic medical conditions including hydrocephalus, where cerebrospinal fluid flow in implanted ventriculoperitoneal shunts is of critical importance. However, quantified analysis of biological fluid flow is often frustrated by the need for invasive fluid access, the use of bulky wired electronics that tether the patient, and motion artifacts in skin-mounted probes. Rhaeos’ novel Epidermal Thermal Flow Sensor technology is designed to overcome these limitations by enabling a small, wireless, flexible device that gently adheres to the skin like a soft bandage. Novel mechanical and thermal engineering approaches result in a sensor that can measure flow-induced temperature responses on skin with a precision of one hundredth of a degree. These improvements, combined with advanced analytics, enable reliable flow measurements with incredible precision down to a few microliters per minute. “The challenge in biological flow sensing is getting useful signals without physically contacting the fluid and without immobilizing the patient,” says R. Chad Webb, PhD, chief technical officer. “This technology overcomes both challenges by mechanically matching the sensor to the skin surface, eliminating motion-induced measurement noise and enabling reliable detection of the subtle flow-induced thermal responses”. The technology has been demonstrated in multiple pilot studies showing effectiveness across a range of healthcare applications, with peer-reviewed publications in Nature and Science family journals, among others. The technology is also a key enabler of FlowSense, a Rhaeos product currently being used in a pivotal clinical trial for monitoring cerebrospinal fluid flow in hydrocephalus shunts. “The ability to noninvasively measure flow through biological systems is broadly useful for a number of medical applications,” says Siddharth R. Krishnan, PhD, Rhaeos Co-Founder. “We’re very excited about the potential to improve care for patients with hydrocephalus, where the measurement of cerebrospinal fluid flow through implanted shunt systems could allow us to identify aberrant patterns and malfunctions more efficiently.” U.S. Patent No. 11,160,458, “Epidermal Devices for Analysis of Temperature and Thermal Transport Characteristics”, describes sensor designs and analytical methods for thermal analysis of tissue, including noninvasively monitoring fluids such as blood flow. Meanwhile, U.S. Patent No. 11,259,754, “Wireless and Noninvasive Epidermal Electronics,” describes conformable devices to measure subdermal fluid flow and related methods. These novel devices and methods enable the detection of thermal flow signals by employing key materials, geometries, and signal processing techniques. Rhaeos, Inc. has exclusive worldwide rights to commercialize these inventions as part of a broad intellectual property portfolio generated internally and licensed from Northwestern University and the University of Illinois. Share:

Rhaeos Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Rhaeos Rank

  • When was Rhaeos founded?

    Rhaeos was founded in 2018.

  • Where is Rhaeos's headquarters?

    Rhaeos's headquarters is located at 2123 Dewey Ave, Evanston.

  • What is Rhaeos's latest funding round?

    Rhaeos's latest funding round is Seed VC.

  • How much did Rhaeos raise?

    Rhaeos raised a total of $2.54M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.